| P50 | author | Laure Marignol | Q57093558 |
| | Anne Hansen Ree | Q89880872 |
| | Kathrine Røe Redalen | Q39052016 |
| P2093 | author name string | Dag Rune Olsen | |
| | Åse Bratland | |
| | Harald Bull Ragnum | |
| | Ljiljana Vlatkovic | |
| | Marie Grøn Saelen | |
| P2860 | cites work | CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma | Q52829169 |
| | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | Q54686436 |
| | Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade | Q80346005 |
| | Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells | Q80438682 |
| | Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence | Q81098692 |
| | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | The protein kinase complement of the human genome | Q24324497 |
| | Exploiting tumour hypoxia in cancer treatment | Q28264146 |
| | Hypoxia--a key regulatory factor in tumour growth | Q29547318 |
| | Targeting cancer with small molecule kinase inhibitors | Q29547395 |
| | Molecular regulation of angiogenesis and lymphangiogenesis | Q29616150 |
| | Signaling--2000 and beyond | Q29617413 |
| | Tumorigenesis and the angiogenic switch | Q29619849 |
| | Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response | Q30573416 |
| | The Stat family in cytokine signaling | Q34180677 |
| | genenames.org: the HGNC resources in 2011. | Q34456662 |
| | Androgens and prostate cancer | Q35571886 |
| | Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B | Q36672274 |
| | Hypoxia in prostate cancer: a powerful shield against tumour destruction? | Q37107636 |
| | The relevance of a hypoxic tumour microenvironment in prostate cancer | Q37627310 |
| | EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. | Q37840406 |
| | Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer. | Q37854477 |
| | Optimizing targeted cancer therapy: towards clinical application of systems biology approaches | Q37884899 |
| | Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo | Q39610401 |
| | Hypoxia activates the IGF-1 expression through STAT5b in human HepG2 cells | Q40131696 |
| | Hypoxia increases androgen receptor activity in prostate cancer cells | Q40278754 |
| | Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells | Q40651643 |
| | A new human prostate carcinoma cell line, 22Rv1. | Q40933318 |
| | Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation | Q40936743 |
| | A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia | Q41831434 |
| | Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling | Q42950470 |
| | pVHL-independent ubiquitination of HIF1alpha and its stabilization by cobalt ion. | Q44480238 |
| | Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score | Q46237005 |
| | Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation | Q47745076 |
| | Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings | Q49028556 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | e63723 | |
| P577 | publication date | 2013-05-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer | |
| P478 | volume | 8 | |